15.88
-0.28 (-1.73%)
| Previous Close | 16.16 |
| Open | 16.07 |
| Volume | 122,467 |
| Avg. Volume (3M) | 285,970 |
| Market Cap | 729,797,184 |
| Price / Earnings (TTM) | 33.79 |
| Price / Sales | 1.08 |
| Price / Book | 0.590 |
| 52 Weeks Range | |
| Earnings Date | 18 Feb 2025 - 24 Feb 2025 |
| Profit Margin | 2.30% |
| Operating Margin (TTM) | 9.68% |
| Diluted EPS (TTM) | 0.470 |
| Quarterly Revenue Growth (YOY) | -0.50% |
| Total Debt/Equity (MRQ) | 16.44% |
| Current Ratio (MRQ) | 2.22 |
| Operating Cash Flow (TTM) | 55.50 M |
| Levered Free Cash Flow (TTM) | 140.15 M |
| Return on Assets (TTM) | 2.08% |
| Return on Equity (TTM) | 1.77% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Avanos Medical, Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | 1.5 |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -0.13 |
|
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 2.90% |
| % Held by Institutions | 96.11% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BLACKFORD GARY | 15.83 | - | 12,003 | 190,007 |
| EGBUONU-DAVIS LISA | 15.83 | - | 12,003 | 190,007 |
| FRANCHINI INDRANI LALL | 15.83 | - | 12,003 | 190,007 |
| OLEARY PATRICK J | 15.83 | - | 12,003 | 190,007 |
| SHIMER JULIE ANN | 15.83 | - | 12,003 | 190,007 |
| Aggregate Net Quantity | 60,015 | |||
| Aggregate Net Value ($) | 950,037 | |||
| Aggregate Avg. Buy ($) | 15.83 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| SHIMER JULIE ANN | Director | 02 Jan 2025 | Acquired (+) | 12,003 | 15.83 | 190,007 |
| OLEARY PATRICK J | Director | 02 Jan 2025 | Acquired (+) | 12,003 | 15.83 | 190,007 |
| FRANCHINI INDRANI LALL | Director | 02 Jan 2025 | Acquired (+) | 12,003 | 15.83 | 190,007 |
| EGBUONU-DAVIS LISA | Director | 02 Jan 2025 | Acquired (+) | 12,003 | 15.83 | 190,007 |
| BLACKFORD GARY | Director | 02 Jan 2025 | Acquired (+) | 12,003 | 15.83 | 190,007 |
| Date | Type | Details |
|---|---|---|
| 06 Jan 2025 | Announcement | Avanos Medical, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference |
| 12 Nov 2024 | Announcement | Avanos Medical, Inc. to Present at the Stifel 2024 Healthcare Conference |
| 11 Nov 2024 | Announcement | ON-Q* Elastomeric Infusion Pump and ambIT* Disposable Electronic Infusion Pump to Receive Separate Payment Under NOPAIN Act Starting January 1, 2025 |
| 08 Nov 2024 | Announcement | Avanos Medical, Inc. to Present at the UBS Healthcare Conference 2024 |
| 05 Nov 2024 | Announcement | Avanos Medical Launches New CORGRIP® SR |
| 30 Oct 2024 | Announcement | Avanos Medical, Inc. Announces Third Quarter 2024 Results, retirement of CEO |
| 23 Oct 2024 | Announcement | Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2024 Financial Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |